REN Pharmaceuticals Obtains $1,500,000 New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=51db33d6-e5fe-487a-9e58-71349f06b483&Preview=1 -
Date
6/30/2008 -
Company Name
REN Pharmaceuticals -
Mailing Address
270 E. Grand Ave. South San Francisco, CA 94080 -
Company Description
The company’s mission is to develop and commercialize breakthrough therapeutics for renal diseases and associated cardio-renal diseases. -
Website
http://www.renpharma.com -
Transaction Type
Venture Equity -
Transaction Amount
$1,500,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Sanderling Ventures
